Cargando…
Pubertal Timing and Growth Dynamics in Children With Severe Primary IGF-1 Deficiency: Results From the European Increlex(®) Growth Forum Database Registry
BACKGROUND: Puberty is delayed in untreated children and adolescents with severe primary IGF-1 deficiency (SPIGFD); to date, it has not been reported whether recombinant human insulin-like growth factor-1 mecasermin (rhIGF-1) treatment affects this. Pubertal growth outcomes were extracted from the E...
Autores principales: | Bang, Peter, Polak, Michel, Perrot, Valérie, Sert, Caroline, Shaikh, Haris, Woelfle, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895479/ https://www.ncbi.nlm.nih.gov/pubmed/35250870 http://dx.doi.org/10.3389/fendo.2022.812568 |
Ejemplares similares
-
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
por: Bang, Peter, et al.
Publicado: (2020) -
Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment
por: Kamil, Grubczak, et al.
Publicado: (2022) -
Secular Trends on Birth Parameters, Growth, and Pubertal Timing in Girls with Turner Syndrome
por: Woelfle, Joachim, et al.
Publicado: (2018) -
Effectiveness and Overall Safety of NutropinAq(®) for Growth Hormone Deficiency and Other Paediatric Growth Hormone Disorders: Completion of the International Cooperative Growth Study, NutropinAq(®) European Registry (iNCGS)
por: Coutant, Regis, et al.
Publicado: (2021) -
Growth Hormone Mediates Pubertal Skeletal Development Independent of Hepatic IGF-1 Production
por: Courtland, Hayden-William, et al.
Publicado: (2011)